Question 1

What is Ernexa Therapeutics?

Accepted Answer

Ernexa Therapeutics is a Entity.

Question 2

How often does Ernexa Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Ernexa Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 09, 2026.

Question 4

When was Ernexa Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 09, 2026.

Question 5

What is Ernexa Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Ernexa Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Ernexa Therapeutics?

Accepted Answer

Ernexa Therapeutics ERNA-101 Ovarian Cancer Update (Jun 09, 2026, 6 articles).

Question 8

How did the "Ernexa Therapeutics ERNA-101 Ovarian Cancer Update" event impact Ernexa Therapeutics?

Accepted Answer

Ernexa Therapeutics is the company developing ERNA-101 and ERNA-201, novel cell therapies for advanced cancer and autoimmune diseases. This event highlights the potential of their ERNA-101 program for ovarian cancer, which could significantly boost the company's market position and stock value.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.